Suh, Yang-Gun <br/><br/>
High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II-III esophageal cancer.  [electronic resource] 

 -  Japanese journal of clinical oncology  Jun 2014 
 - 534-40 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1465-3621 
<br/><br/><label>Standard No.: </label>10.1093/jjco/hyu047  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chemoradiotherapy--adverse effects<br/>Cisplatin--administration & dosage<br/>Disease-Free Survival<br/>Docetaxel<br/>Dose-Response Relationship, Radiation<br/>Drug Administration Schedule<br/>Esophageal Neoplasms--drug therapy<br/>Esophageal Stenosis--etiology<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Incidence<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Platinum Compounds--administration & dosage<br/>Prognosis<br/>Radiation Pneumonitis--etiology<br/>Radiotherapy Dosage<br/>Retrospective Studies<br/>Risk Factors<br/>Taxoids--administration & dosage<br/>Treatment Failure<br/>Treatment Outcome